Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 6;13(9):e0202597.
doi: 10.1371/journal.pone.0202597. eCollection 2018.

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI

Affiliations

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI

Vincent Perlbarg et al. PLoS One. .

Abstract

Parkinson's disease is characterized by neurodegeneration of the dopaminergic neurons in the substantia nigra pars compacta. The 6-hydroxydopamine (6-OHDA) rat model has been used to study neurodegeneration in the nigro-striatal dopaminergic system. The goal of this study was to evaluate the reliability of diffusion MRI and resting-state functional MRI biomarkers in monitoring neurodegeneration in the 6-OHDA rat model assessed by quantitative histology. We performed a unilateral injection of 6-OHDA in the striatum of Sprague Dawley rats to produce retrograde degeneration of the dopamine neurons in the substantia nigra pars compacta. We carried out a longitudinal study with a multi-modal approach combining structural and functional MRI together with quantitative histological validation to follow the effects of the lesion. Functional and structural connectivity were assessed in the brain of 6-OHDA rats and sham rats (NaCl injection) at 3 and 6 weeks post-lesioning using resting-state functional MRI and diffusion-weighted. Our results showed (i) increased functional connectivity in ipsi- and contra-lesioned regions of the cortico-basal ganglia network pathway including the motor cortex, the globus pallidus, and the striatum regions at 3 weeks; (ii) increased fractional anisotropy (FA) in the ipsi- and contralateral striatum of the 6-OHDA group at 3 weeks, and increased axial diffusivity (AD) and mean diffusivity in the ipsilateral striatum at 6 weeks; (iii) a trend for increased FA in both substantia nigra of the 6-OHDA group at 3 weeks. Optical density measurements of tyrosine-hydroxylase (TH) staining of the striatum showed good correlations with the FA and AD measurements in the striatum. No correlations were found between the number of TH-stained dopaminergic neurons and MRI measurements in the substantia nigra. This study suggested that (i) FA and AD were reliable biomarkers to evaluate neurodegeneration in the cortico-basal ganglia network of the 6-OHDA model, (ii) diffusion MRI and resting-state functional MRI (rsfMRI) were not sensitive enough to detect changes in the substantia nigra in this model.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Group FC maps from left and right striatum for the sham and 6-OHDA groups.
Maps are expressed as Z-scores. The 6-OHDA group showed larger bilateral patterns of FC than the sham group at 3 weeks but the difference was not significant.
Fig 2
Fig 2. FC matrices within the motor network at 3 weeks and 6 weeks.
Red (resp. Blue) links indicate significant positive (resp. negative) difference in FC between the 6-OHDA group and the sham group.
Fig 3
Fig 3. Diffusion metrics in the STR and the SN at 3 and 6 weeks.
AD, RD, MD are in mm2/s. Significant results are indicated using *p<0.05 and **p<0.01.
Fig 4
Fig 4. Scatter plot of fractional anisotropy and axial diffusivity versus optical density values.
The diffusion values are measured within the right STR for all exams. Circles correspond to 3 weeks exams and squares to 6 weeks exams. Black markers stand for 6-OHDA group and white markers for sham group.

Similar articles

Cited by

References

    1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20(4):415–455. - PubMed
    1. Lehéricy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, et al.; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group. The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward. Mov Disord. 2017;32(4):510–525. 10.1002/mds.26968 - DOI - PubMed
    1. Goveas J, O'Dwyer L, Mascalchi M, Cosottini M, Diciotti S, De Santis S, et al. Diffusion-MRI in neurodegenerative disorders. Magn Reson Imaging 215;33(7): 853–876. 10.1016/j.mri.2015.04.006 - DOI - PubMed
    1. Atkinson-Clementa C, Pintoa S, Eusebio A, Coulon O. Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis. Neuroimage: Clinical 2017;16: 98–110. - PMC - PubMed
    1. Cochrane CJ, and Ebmeier KP. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 2013. February 26;80(9):857–64. 10.1212/WNL.0b013e318284070c - DOI - PMC - PubMed

Publication types

MeSH terms